Abstract

Exudative age-related maculopathy (ARM) is the leading cause of vision loss in the United States among the elderly.^1,2 The goal of our research is to identify those most at risk for exudative ARM before the development of exudative and neovascular complications and before severe loss of acuity. Those identified as "Most At Risk" could monitor their vision carefully for visual distortion or loss or for further flicker sensitivity loss, allowing early clinical evaluation and possible treatment should exudative symptoms appear. Predictors of exudative ARM could also provide information about the progress and rate of development of pre-exudative stages of ARM and could help to evaluate proposed treatments for the earlier stages of ARM.

© 1993 Optical Society of America